These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 27254086)

  • 41. Infant serotonin transporter (SLC6A4) promoter genotype is associated with adverse neonatal outcomes after prenatal exposure to serotonin reuptake inhibitor medications.
    Oberlander TF; Bonaguro RJ; Misri S; Papsdorf M; Ross CJ; Simpson EM
    Mol Psychiatry; 2008 Jan; 13(1):65-73. PubMed ID: 17519929
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Maternal fluoxetine treatment in the postpartum period: effects on platelet serotonin and plasma drug levels in breastfeeding mother-infant pairs.
    Epperson CN; Jatlow PI; Czarkowski K; Anderson GM
    Pediatrics; 2003 Nov; 112(5):e425. PubMed ID: 14595087
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Serotonin Selective Reuptake Inhibitor Treatment Improves Cognition and Grey Matter Atrophy but not Amyloid Burden During Two-Year Follow-Up in Mild Cognitive Impairment and Alzheimer's Disease Patients with Depressive Symptoms.
    Brendel M; Sauerbeck J; Greven S; Kotz S; Scheiwein F; Blautzik J; Delker A; Pogarell O; Ishii K; Bartenstein P; Rominger A;
    J Alzheimers Dis; 2018; 65(3):793-806. PubMed ID: 30010116
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Major depression and antidepressant treatment: impact on pregnancy and neonatal outcomes.
    Wisner KL; Sit DK; Hanusa BH; Moses-Kolko EL; Bogen DL; Hunker DF; Perel JM; Jones-Ivy S; Bodnar LM; Singer LT
    Am J Psychiatry; 2009 May; 166(5):557-66. PubMed ID: 19289451
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Use of SSRIs during pregnancy and possible consequences for the development of the child].
    van der Veere CN; Bos AF
    Ned Tijdschr Geneeskd; 2007 Dec; 151(52):2873-4. PubMed ID: 18257430
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Maternal treatment with selective serotonin reuptake inhibitors during pregnancy and delayed neonatal adaptation: a population-based cohort study.
    Cornet MC; Wu YW; Forquer H; Avalos LA; Sriram A; Scheffler AW; Newman TB; Kuzniewicz MW
    Arch Dis Child Fetal Neonatal Ed; 2024 Apr; 109(3):294-300. PubMed ID: 38071585
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Genome-wide DNA methylation in neonates exposed to maternal depression, anxiety, or SSRI medication during pregnancy.
    Non AL; Binder AM; Kubzansky LD; Michels KB
    Epigenetics; 2014 Jul; 9(7):964-72. PubMed ID: 24751725
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The Association Between Antenatal Exposure to Selective Serotonin Reuptake Inhibitors and Autism: A Systematic Review and Meta-Analysis.
    Brown HK; Hussain-Shamsy N; Lunsky Y; Dennis CE; Vigod SN
    J Clin Psychiatry; 2017 Jan; 78(1):e48-e58. PubMed ID: 28129495
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Selective serotonin reuptake inhibitors in pregnancy.
    Bellissima V; Ververs TF; Visser GH; Gazzolo D
    Curr Med Chem; 2012; 19(27):4554-61. PubMed ID: 22876893
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Maternal SSRI exposure increases the risk of autistic offspring: A meta-analysis and systematic review.
    Andalib S; Emamhadi MR; Yousefzadeh-Chabok S; Shakouri SK; Høilund-Carlsen PF; Vafaee MS; Michel TM
    Eur Psychiatry; 2017 Sep; 45():161-166. PubMed ID: 28917161
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prenatal exposure to selective serotonin reuptake inhibitors and serotonin norepinephrine reuptake inhibitors and risk for persistent pulmonary hypertension of the newborn: a systematic review, meta-analysis, and network meta-analysis.
    Masarwa R; Bar-Oz B; Gorelik E; Reif S; Perlman A; Matok I
    Am J Obstet Gynecol; 2019 Jan; 220(1):57.e1-57.e13. PubMed ID: 30170040
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Antenatal depression and antidepressants during pregnancy: unraveling the complex interactions for the offspring.
    Olivier JD; Åkerud H; Sundström Poromaa I
    Eur J Pharmacol; 2015 Apr; 753():257-62. PubMed ID: 25094036
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Profiling placental DNA methylation associated with maternal SSRI treatment during pregnancy.
    Inkster AM; Konwar C; Peñaherrera MS; Brain U; Khan A; Price EM; Schuetz JM; Portales-Casamar É; Burt A; Marsit CJ; Vaillancourt C; Oberlander TF; Robinson WP
    Sci Rep; 2022 Dec; 12(1):22576. PubMed ID: 36585414
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Alcohol exposure in utero is associated with decreased gray matter volume in neonates.
    Donald KA; Fouche JP; Roos A; Koen N; Howells FM; Riley EP; Woods RP; Zar HJ; Narr KL; Stein DJ
    Metab Brain Dis; 2016 Feb; 31(1):81-91. PubMed ID: 26616173
    [TBL] [Abstract][Full Text] [Related]  

  • 55. SSRI antidepressants and persistent pulmonary hypertension in newborns.
    Prescrire Int; 2008 Aug; 17(96):156. PubMed ID: 19492488
    [TBL] [Abstract][Full Text] [Related]  

  • 56. White Matter Indices of Medication Response in Major Depression: A Diffusion Tensor Imaging Study.
    Davis AD; Hassel S; Arnott SR; Harris J; Lam RW; Milev R; Rotzinger S; Zamyadi M; Frey BN; Minuzzi L; Strother SC; MacQueen GM; Kennedy SH; Hall GB
    Biol Psychiatry Cogn Neurosci Neuroimaging; 2019 Oct; 4(10):913-924. PubMed ID: 31471185
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Safety of Selective Serotonin Reuptake Inhibitors in Pregnancy: A Review of Current Evidence.
    Alwan S; Friedman JM; Chambers C
    CNS Drugs; 2016 Jun; 30(6):499-515. PubMed ID: 27138915
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Obstetrical and neonatal outcomes after prenatal exposure to selective serotonin reuptake inhibitors: the relevance of dose.
    Roca A; Garcia-Esteve L; Imaz ML; Torres A; Hernández S; Botet F; Gelabert E; Subirà S; Plaza A; Valdés M; Martin-Santos R
    J Affect Disord; 2011 Dec; 135(1-3):208-15. PubMed ID: 21890210
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prenatal depression exposure alters white matter integrity and neurodevelopment in early childhood.
    Roos A; Wedderburn CJ; Fouche JP; Joshi SH; Narr KL; Woods RP; Zar HJ; Stein DJ; Donald KA
    Brain Imaging Behav; 2022 Jun; 16(3):1324-1336. PubMed ID: 35000066
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Behavior and inhibitory control in children with prenatal exposure to antidepressants and medically untreated depression.
    Hermansen TK; Røysamb E; Augusti EM; Melinder A
    Psychopharmacology (Berl); 2016 Apr; 233(8):1523-35. PubMed ID: 26924747
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.